Advance in Interleukin-6 in Central Nervous System (review)

  • LIU Qiu-yan ,
  • ZHANG Lei-hong ,
  • YU Xiao-ming ,
  • YUAN Ai-yun
Expand
  • Department of Neurological Rehabilitation, Qingdao Women and Children’s Hospital, Qingdao, Shandong 266034, China

Received date: 2018-11-16

  Revised date: 2018-12-20

  Online published: 2019-05-29

Supported by

Projects of Medical and Health Technology Development Program in Shandong Province (No. 2015WS0352), the Projects of Medical Science Guidance Program in Qingdao City (No. 2016-WJZD084) and the Qingdao Outstanding Health Professional Development Fund (No. 2017.1-2019.12).

Abstract

The central nervous system can produce a variety of neuroimmune factors including interleukin-6. This article reviewed the expression and signaling pathways of interleukin-6 and its receptors in the central nervous system, and advances in interleukin-6 in the regulation of central nervous system related diseases, cognitive behaviors and synaptic function, which suggested that interleukin-6 involves in various physiological or pathological functions in the central nervous system and affects central nervous system in multiple layers such as protein expression, signal transduction, neurological function, and synaptic transmission. Interleukin-6 is expected to be a biological marker in the specific state of the central nervous system. In addition, interleukin-6 can regulate the function of neurons and synapses and is an important molecule involved in synaptic transmission, synaptic plasticity, and learning and memory. Strengthening the research on the biological function and mechanism of interleukin-6 and timely regulating the interleukin-6 expression will provide a new perspective for the treatment of the central nervous system related diseases.

Cite this article

LIU Qiu-yan , ZHANG Lei-hong , YU Xiao-ming , YUAN Ai-yun . Advance in Interleukin-6 in Central Nervous System (review)[J]. Chinese Journal of Rehabilitation Theory and Practice, 2019 , 25(5) : 540 -545 . DOI: 10.3969/j.issn.1006-9771.2019.05.007

References

1 CasaultC, Al SultanA S, BanoeiM, et al. Cytokine responses in severe traumatic brain injury: where there is smoke, is there fire? [J]. Neurocrit Care, 2018. doi: 10.1007/s12028-018-0522-z. [Epub ahead of print].
2 Olde EngberinkA, HernandezR, De GraanP, et al. Rapamycin-sensitive late-LTP is enhanced in the hippocampus of IL-6 transgenic mice [J]. Neuroscience, 2017, 367: 200-210.
3 KempurajD, ThangavelR, NatteruP A, et al. Neuroinflammation induces neurodegeneration [J]. J Neurol Neurosurg Spine, 2016, 1(1). pii: 1003.
4 LiuY, ZhangY, ZhengX, et al. Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice [J]. J Neuroinflammation, 2018, 15(1): 112.
5 HernandezR V, PuroA C, ManosJ C, et al. Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function [J]. Neuropharmacology, 2016, 103: 27-43.
6 VezzaniA, VivianiB. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability [J]. Neuropharmacology, 2015, 96(Pt A): 70-82.
7 LevinS G, GodukhinO V. Modulating effect of cytokines on mechanisms of synaptic plasticity in the brain [J]. Biochemistry (Mosc), 2017, 82(3): 264-274.
8 YangY, Boza-SerranoA, DunningC J R, et al. Inflammation leads to distinct populations of extracellular vesicles from microglia [J]. J Neuroinflammation, 2018, 15(1): 168.
9 JuttlerE, TarabinV, SchwaningerM. Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity [J]. Neuroscientist, 2002, 8(3): 268-275.
10 BergamaschiA, CorsiM, GarnierM J. Synergistic effects of cAMP-dependent signalling pathways and IL-1 on IL-6 production by H19-7/IGF-IR neuronal cells [J]. Cell Signal, 2006, 18(10): 1679-1684.
11 TsakiriN, KimberI, RothwellN J, et al. Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones [J]. Mol Cell Neurosci, 2008, 38(2): 259-265.
12 StanleyA C, LacyP. Pathways for cytokine secretion [J]. Physiology (Bethesda), 2010, 25(4): 218-229.
13 TsakiriN, KimberI, RothwellN J, et al. Mechanisms of interleukin-6 synthesis and release induced by interleukin-1 and cell depolarisation in neurones [J]. Mol Cell Neurosci, 2008, 37(1): 110-118.
14 Rose-JohnS, SchellerJ, ElsonG, et al. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer [J]. J Leukoc Biol, 2006, 80(2): 227-236.
15 GruolD L. IL-6 regulation of synaptic function in the CNS [J]. Neuropharmacology, 2015, 96(Pt A): 42-54.
16 BurtonM D, JohnsonR W. Interleukin-6 trans-signaling in the senescent mouse brain is involved in infection-related deficits in contextual fear conditioning [J]. Brain Behav Immun, 2012, 26(5): 732-738.
17 CampbellI L, ErtaM, LimS L, et al. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain [J]. J Neurosci, 2014, 34(7): 2503-2513.
18 Garcia-OscosF, SalgadoH, HallS, et al. The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling [J]. Biol Psychiatry, 2012, 71(7): 574-582.
19 HampelH, HaslingerA, ScheloskeM, et al. Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain[J]. Eur Arch Psychiatry Clin Neurosci, 2005, 255(4): 269-278.
20 D'arcangeloG, TancrediV, OnofriF, et al. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex [J]. Eur J Neurosci, 2000, 12(4): 1241-1252.
21 MuraseS, McKayR D. Neuronal activity-dependent STAT3 localization to nucleus is dependent on Tyr-705 and Ser-727 phosphorylation in rat hippocampal neurons [J]. Eur J Neurosci, 2014, 39(4): 557-565.
22 NicolasC S, PeineauS, AmiciM, et al. The JAK/STAT pathway is involved in synaptic plasticity [J]. Neuron, 2012, 73(2): 374-390.
23 SilvaT C C, De Jesus Menezes-FilhoN, De Faria LopesG P, et al. Specific cytostatic and cytotoxic effect of dihydrochelerythrine in glioblastoma cells: role of NF-kB/b-catenin and STAT3/IL-6 pathways [J]. Anticancer Agents Med Chem, 2018. doi: 10.2174/1871520618666180412122101. [Epub ahead of print].
24 GuW, WangY, QiuZ, et al. Maternal exposure to nonylphenol during pregnancy and lactation induces microglial cell activation and pro-inflammatory cytokine production in offspring hippocampus [J]. Sci Total Environ, 2018, 634: 525-533.
25 AtzoriM, Garcia-OscosF, MendezJ A. Role of IL-6 in the etiology of hyperexcitable neuropsychiatric conditions: experimental evidence and therapeutic implications [J]. Future Med Chem, 2012, 4(17): 2177-2192.
26 HilesS A, BakerA L, De MalmancheT, et al. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity [J]. Brain Behav Immun, 2012, 26(7): 1180-1188.
27 JonesK A, ThomsenC. The role of the innate immune system in psychiatric disorders [J]. Mol Cell Neurosci, 2013, 53: 52-62.
28 TraperoI, CauliO. Interleukin 6 and cognitive dysfunction[J]. Metab Brain Dis, 2014, 29(3): 593-608.
29 WeiH, AlbertsI, LiX. Brain IL-6 and autism [J]. Neuroscience, 2013, 252: 320-325.
30 SwardfagerW, LanctotK, RothenburgL, et al. A meta-analysis of cytokines in Alzheimer's disease [J]. Biol Psychiatry, 2010, 68(10): 930-941.
31 LutermanJ D, HaroutunianV, YemulS, et al. Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia [J]. Arch Neurol, 2000, 57(8): 1153-1160.
32 ImamuraK, HishikawaN, OnoK, et al. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains [J]. Acta Neuropathol, 2005, 109(2): 141-150.
33 Wada-IsoeK, WakutaniY, UrakamiK, et al. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients [J]. Acta Neurol Scand, 2004, 110(2): 124-127.
34 LindqvistD, JanelidzeS, HagellP, et al. Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity [J]. Biol Psychiatry, 2009, 66(3): 287-292.
35 JanelidzeS, MatteiD, WestrinA, et al. Cytokine levels in the blood may distinguish suicide attempters from depressed patients [J]. Brain Behav Immun, 2011, 25(2): 335-339.
36 Elderkin-ThompsonV, IrwinM R, HellemannG, et al. Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults [J]. Am J Geriatr Psychiatry, 2012, 20(9): 753-763.
37 SasayamaD, HattoriK, WakabayashiC, et al. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder [J]. J Psychiatr Res, 2013, 47(3): 401-406.
38 MasiA, QuintanaD S, GlozierN, et al. Cytokine aberrations in autism spectrum disorder: a systematic review and meta-analysis [J]. Mol Psychiatry, 2015, 20(4): 440-446.
39 WeiH, ChadmanK K, McCloskeyD P, et al. Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors [J]. Biochim Biophys Acta, 2012, 1822(6): 831-842.
40 WeiH, ZouH, SheikhA M, et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation [J]. J Neuroinflammation, 2011, 8: 52.
41 WoolfendenS, SarkozyV, RidleyG, et al. A systematic review of two outcomes in autism spectrum disorder-epilepsy and mortality [J]. Dev Med Child Neurol, 2012, 54(4): 306-312.
42 Lorigados PedreL, Morales ChaconL M, Orozco SuarezS, et al. Inflammatory mediators in epilepsy [J]. Curr Pharm Des, 2013, 19(38): 6766-6772.
43 MaoL Y, DingJ, PengW F, et al. Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients [J]. Epilepsia, 2013, 54(9): e142-e145.
44 YuN, DiQ, HuY, et al. A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure [J]. Neurosci Lett, 2012, 514(1): 110-115.
45 DoneganJ J, GirottiM, WeinbergM S, et al. A novel role for brain interleukin-6: facilitation of cognitive flexibility in rat orbitofrontal cortex [J]. J Neurosci, 2014, 34(3): 953-962.
46 DinelA L, AndreC, AubertA, et al. Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome [J]. PLoS One, 2011, 6(9): e24325.
47 KulikovA V, FursenkoD V, KhotskinN V, et al. Spatial learning in the Morris water maze in mice genetically different in the predisposition to catalepsy: the effect of intraventricular treatment with brain-derived neurotrophic factor [J]. Pharmacol Biochem Behav, 2014, 122: 266-272.
48 ZhuB, DongY, XuZ, et al. Sleep disturbance induces neuroinflammation and impairment of learning and memory [J]. Neurobiol Dis, 2012, 48(3): 348-355.
49 Sukoff RizzoS J, NealS J, HughesZ A, et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes [J]. Transl Psychiatry, 2012, 2: e199.
50 YangM, KimJ, KimJ S, et al. Hippocampal dysfunctions in tumor-bearing mice [J]. Brain Behav Immun, 2014, 36: 147-155.
51 MonjeF J, CabaticM, DivischI, et al. Constant darkness induces IL-6-dependent depression-like behavior through the NF-kappaB signaling pathway [J]. J Neurosci, 2011, 31(25): 9075-9083.
52 PinedaE, ShinD, SankarR, et al. Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms [J]. Epilepsia, 2010, 51 (Suppl 3): 110-114.
53 LiG, BauerS, NowakM, et al. Cytokines and epilepsy [J]. Seizure, 2011, 20(3): 249-256.
54 VezzaniA, BalossoS, RavizzaT. The role of cytokines in the pathophysiology of epilepsy [J]. Brain Behav Immun, 2008, 22(6): 797-803.
55 ChibaT, YamadaM, AisoS. Targeting the JAK2/STAT3 axis in Alzheimer's disease [J]. Expert Opin Ther Targets, 2009, 13(10): 1155-1167.
56 Ben AchourS, Pont-LezicaL, BechadeC, et al. Is astrocyte calcium signaling relevant for synaptic plasticity? [J]. Neuron Glia Biol, 2010, 6(3): 147-155.
57 PannaschU, RouachN. Emerging role for astroglial networks in information processing: from synapse to behavior [J]. Trends Neurosci, 2013, 36(7): 405-417.
58 NelsonT E, Olde EngberinkA, HernandezR, et al. Altered synaptic transmission in the hippocampus of transgenic mice with enhanced central nervous systems expression of interleukin-6 [J]. Brain Behav Immun, 2012, 26(6): 959-971.
59 SamlandH, Huitron-ResendizS, MasliahE, et al. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6 [J]. J Neurosci Res, 2003, 73(2): 176-187.
60 TancrediV, D'antuonoM, CafeC, et al. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK [J]. J Neurochem, 2000, 75(2): 634-643.
61 JankowskyJ L, DerrickB E, PattersonP H. Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques [J]. Learn Mem, 2000, 7(6): 400-412.
62 Del ReyA, BalschunD, WetzelW, et al. A cytokine network involving brain-borne IL-1beta, IL-1ra, IL-18, IL-6, and TNFalpha operates during long-term potentiation and learning [J]. Brain Behav Immun, 2013, 33: 15-23.
Outlines

/